Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for Arterial Stiffness in Peritoneal Dialysis Patients
NCT01143987Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jun 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by The Chinese University of Hong Kong. Primary endpoint: Aortic pulse wave velocity at 52 weeks. Started Jun 2010; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT01143987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143987.